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Dysregulations in the brain serotonergic system and exposure to environmental
stressors have been implicated in the development of major depressive disorder.
Here, we investigate the interactions between the stress and serotonergic systems
by characterizing the behavioral and biochemical effects of chronic stress applied
during early-life or adulthood in wild type (WT) mice and mice with deficient tryptophan
hydroxylase 2 (TPH2) function. We showed that chronic mild stress applied in
adulthood did not affect the behaviors and serotonin levels of WT and TPH2
knock-in (KI) mice. Whereas, maternal separation (MS) stress increased anxiety-
and depressive-like behaviors of WT mice, with no detectable behavioral changes
in TPH2 KI mice. Biochemically, we found that MS WT mice had reduced brain
serotonin levels, which was attributed to increased expression of monoamine oxidase
A (MAO A). The increased MAO A expression was detected in MS WT mice at
4 weeks old and adulthood. No change in TPH2 expression was detected. To
determine whether a pharmacological stressor, dexamethasone (Dex), will result in
similar biochemical results obtained from MS, we used an in vitro system, SH-
SY5Y cells, and found that Dex treatment resulted in increased MAO A expression
levels. We then treated WT mice with Dex for 5 days, either during postnatal
days 7–11 or adulthood. Both groups of Dex treated WT mice had reduced basal
corticosterone and glucocorticoid receptors expression levels. However, only Dex
treatment during PND7–11 resulted in reduced serotonin levels and increased MAO
A expression. Just as with MS WT mice, TPH2 expression in PND7–11 Dex-
treated WT mice was unaffected. Taken together, our findings suggest that both
environmental and pharmacological stressors affect the expression of MAO A, and
not TPH2, when applied during the critical postnatal period. This leads to long-lasting
perturbations in the serotonergic system, and results in anxiety- and depressive-like
behaviors.
Keywords: TPH2, maternal separation, chronic mild stress, depression, anxiety, monoamine oxidase A,
dexamethasone, serotonin
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Introduction
Increasing evidence suggest that stress is an important factor
in the etiology of depression in humans (Hammen, 2005; Clark
et al., 2007; Cohen et al., 2007; Heim and Binder, 2012).
The normal physiological response to stress is the activation
of the hypothalamic-pituitary-adrenal (HPA) axis. This results
in the production of corticosteroids that bind to and activate
mineralocorticoid and glucocorticoid receptors, which give rise
to physiological and homeostatic changes downstream (De Kloet,
2004; Smith and Vale, 2006). However, constant activation of
the stress response may cause dysregulations in the HPA axis,
resulting in permanently altered circulating corticosterone levels
(Lanfumey et al., 2008; Vreeburg et al., 2009; Frodl and O’Keane,
2013) or epigenetic changes in the expression of glucocorticoid
receptors (Chung et al., 1999; Meaney and Szyf, 2005). In
addition, there has been increasing consensus that the extent
of adverse outcome following a stressful experience is largely
dependent on the timing, duration and type of stressor (Avital
and Richter-Levin, 2005; Tsoory et al., 2007; Lupien et al., 2009).
In particular, early life stress seems to have long-lasting impacts
on adult behavior. This has been attributed to the fact that the
brain andHPA axis of developing animals are more vulnerable to
stress-induced pre-programming (Matthews, 2002; Champagne
et al., 2009; Huang, 2011; Banerjee et al., 2012).
Dysregulation of the serotonergic system, such as decreased
serotonin synthesis caused by a rare mutation that compromises
the functionality of the tryptophan hydroxylase (TPH) 2 gene
(Zhang et al., 2004, 2005), has also been directly implicated in
the pathophysiology of depression (Asberg et al., 1976; Gao
et al., 2012; Jacobsen et al., 2012a). Interestingly, there are
several interactions between the HPA axis and the serotonergic
system (Fuller and Snoddy, 1980; Chaouloff, 1993; Dinan, 1996;
McAllister-Williams et al., 1998; Porter et al., 2004; Heisler
et al., 2007). For example, serotonergic cell bodies in the brain
have increased glucocorticoid receptor expression (Lanfumey
et al., 2008). In addition, direct manipulation of serotonin
levels in the brain has also been shown to affect the expression
of glucocorticoid receptors (Sémont et al., 2000). Thus, the
serotonin signaling system appears to be a critical point of
intersection between an environmentally driven stress response
and genetic predisposition to depression (Caspi et al., 2003;
Porter et al., 2004; Firk and Markus, 2007; Lanfumey et al.,
2008; Alexander et al., 2009). In mice that had undergone
chronic stress, those with deficient serotonin showed increased
susceptibility to mood disorders as compared to wild type
(WT) mice (Sachs et al., 2013, 2014; Gutknecht et al., 2015). In
rhesus monkeys, a polymorphism in the tryptophan hydroxylase
2 (TPH2) gene, combined with early life experiences caused
changes in the baseline cortisol levels and overactivation of the
HPA axis, as well as behaviors such as aggressive displays (Chen
et al., 2010). As such, stress and serotonergic abnormalities can
act in tandem and interact in determining the severity or the
susceptibility of an individual to mood disorders (Caspi et al.,
2003; Zill et al., 2004; Zhou et al., 2005; Chi et al., 2013).
In this study, we utilized a mouse model of TPH2 deficiency
to determine how congenital serotonergic deficiency affects
the responses to chronic stress. This mouse model has single-
nucleotide polymorphism (SNP) mutation of the TPH2 gene,
which is analogous to that of human patients with major
depressive disorder. These TPH2 knock-in (KI) mice exhibit
reduced serotonin synthesis by 80%, and increased depressive-
or anxiety-like behaviors (Zhang et al., 2005; Beaulieu et al.,
2008; Jacobsen et al., 2012b). As HPA axis response to chronic
stress can differ at different developmental time points, we
also seek to characterize the differences in the adult behaviors
and underlying biochemical mechanisms that occur when
chronic stress paradigms are applied at different time points.
The first time-point is during early life using the maternal
separation (MS) paradigm (Plotsky and Meaney, 1993; Newport
et al., 2002), and the second is during adulthood using the
chronic mild stress paradigm (Willner, 1997; Pothion et al.,
2004).
In order to elucidate the biochemical and neurochemical
effects of stress on the serotonergic system, we used a
pharmacological approach to directly activate the glucocorticoid
receptors. Dexamethasone (Dex) is a synthetic glucocorticoid
that binds to and activates the glucocorticoid receptor, with
minimal mineralocorticoid receptor activation (Meaney and
Aitken, 1985). Here, we used a neuronal cell line, SH-SY5Y
cells, to investigate the effects of Dex in an in vitro system.
Thereafter, we administered Dex to WT mice during two time
points that were comparable to the chronic stress paradigms, one
during early life from postnatal days 7–11 and another during
adulthood.
The pathophysiology of depression involves complex
interactions between environmental, genetic and biochemical
factors. By using both WT and serotonin deficient mice
to analyze the impacts of different types of chronic stress
on behavior and on the serotonergic system, we hope to
gain a clearer understanding of how the stress response and
serotonergic systems interact to lead to depression. This in turn
will allow us to identify targets for therapeutic interventions, in
order to develop better therapies to combat depression.
Materials and Methods
Animals
C57BL/6 WT and TPH2 KI male mice were generated by
heterozygous breeding and genotyped as previously described
(Zhang et al., 2004). Mice were housed in a specific pathogen
free environment, on a 12-h light/dark cycle (lights on 7
a.m. to 7 p.m.) and with food and water available ad libitum.
All experiments were conducted in accordance with national
guidelines for the care and use of laboratory animals for scientific
purposes and with approval from the Institutional Animal Care
and Use Committee (IACUC) of Duke-NUS Graduate Medical
School, Singapore.
Experimental Design for Chronic Stress During
Adulthood
At 8 weeks old, mice were selected to undergo a series of
mild stressors over 4 weeks (Table 1). The mild stressors
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that were applied included: cage tilt of approximately
45◦, overnight wet bedding or bedding removal, 30 min
restraint stress, 6 h water or food deprivation, cage swap
and constant agitation, and isolation where mice were
housed individually overnight. Reversed light cycle was
introduced on Saturdays and Sundays. Tail suspension test
(TST), which was performed on day 26 of the chronic mild
stress paradigm, was used as a stressor and an assay for
depressive-like behavior. Mice were sacrificed at 12 weeks
old, blood was collected, and brain tissue samples were
rapidly dissected and snap frozen. Corticosterone assay and
neurochemical analyses were then carried out on the collected
samples.
Experimental Design for Chronic Stress During
Early Life (Maternal Separation)
Litters were randomly assigned into two groups, non-maternally
separated (non-MS) controls and maternally separated (MS)
groups. Newborn pups were subjected to MS stress for 3 h each
day starting from postnatal day 1 to day 14, and this took place
between 9:00 h and 15:00 h. Pups assigned to the MS group
were separated from the dams and placed on a heated blanket
maintained at 37◦C, in plastic containers with breathable lids.
After the 3 h of separation, the pups were then returned to their
homecage. Control groups were left undisturbed in their home
cage throughout the experiment. At the end of the procedure, all
pups remained undisturbed until weaning at 3 weeks. Behavioral
testing commenced when the mice reached 8 weeks of age. At
the end of the behavioral experiments, control and maternally
separated WT and TPH2 KI mice were sacrificed. The blood
was collected, and the frontal cortex, striatum and brainstem
were rapidly dissected and snap frozen. Additionally, a separate
batch of non-MS and MS mice were sacrificed at 4 weeks,
and brain samples were collected. Neurochemical, and gene
and protein expression analyses were then carried out on brain
samples.
Experimental Design for Dexamethasone
Treatment of SH-SY5Y Cell Line
The human neuroblastoma, SH-SY5Y, cell line was a gift from
Dr. LimKah Leong (National Neuroscience Institute, Singapore).
SH-SY5Y cells were cultured for 16 h in DMEM medium-
high glucose (Sigma-Aldrich, St. Louis, MO, USA), pH 7.3,
supplemented with 10% charcoal/dextran treated FBS (Hyclone™,
USA) to remove endogenous glucocorticoids. After which, cells
were treated with 100 nM Dex (Sigma-Aldrich, St. Louis, MO,
USA) dissolved in dimethyl sulfoxide (DMSO) or a vehicle of
DMSO for another 24 h. After treatment, the cells were pelleted
and stored in −80◦C until gene and protein expression analyses
were carried out.
Experimental Design for Dexamethasone
Treatment of WT Mice
Dexamethasone or vehicle was administered to WT 8 week old
and 7 day old mice. In 8 week old mice, Dex was administered
for five consecutive days, and mice were sacrificed on the
following day. In 7 day old pups, Dex was administered for five
consecutive days from PND7 to PND11, andmice were sacrificed
at 4 weeks of age. Dexamethasone (Sigma-Aldrich, St. Louis, MO,
USA) was first dissolved in ethanol, then subsequently diluted
with autoclaved water to a final concentration of 6% ethanol.
1 mg/kg of Dex was injected intraperitoneally with a 5 ml/kg
injection volume. Vehicle was 6% ethanol. Corticosterone assay,
neurochemical, and gene and protein expression analyses were
then carried out on collected samples.
Behavioral Testing
For all procedures, mice were brought into the testing room
several hours before the test to allow for acclimatization. The
behavior tests were conducted on consecutive days and in the
same sequence: light/dark box, elevated zero maze, and then
tail suspension. All behavioral apparatus were cleaned between
each animal with surface disinfectant and 70% ethanol. In the
light/dark box test, a behavioral test for anxiety (Bourin and
Hascoët, 2003), mice were individually placed into the dark
box (20.32 cm × 40.5 cm × 16 cm), and allowed 10 min of
free exploration. Behavioral measures such as the percentage of
time spent in the light box, horizontal activity in the light box,
latency to enter the light box and the number of transitions
between the two boxes were monitored using the Versamax
program (AccuScan Instruments Inc., Columbus, OH, USA). In
the elevated zero maze, the second test for anxiety (Shepherd
et al., 1994; Rodriguiz and Wetsel, 2006), mice were individually
placed into the closed arm and allowed 5 min for exploration.
The number of transitions from one closed arm to the other
closed arm and the percentage of time spent in the open arm
were scored using JWatcher (UCLA, Los Angeles, CA, USA).
Both control and maternally separated groups underwent TST to
evaluate depressive-like behaviors. Mice were subjected to 6 min
of inescapable stress of being suspended by their tail (Crowley
et al., 2004). Immobility time was defined duration of time in
which the force of the mouse’s movement did not exceed a set
threshold as detected by a strain gauge in the Tail Suspension
Chamber (Med Associates Inc., St. Albans, VT, USA).
Corticosterone Assay
The blood collected was centrifuged at 9.0 rpm for 20 min
at 4◦C. Serum was collected and stored at −80◦C until use.
Corticosterone level was measured using Corticosterone EIA
KIT (Enzo Life Sciences, Exeter, UK) following manufacturer’s
protocol with the following modification: the primary antibody
and conjugate were added serially, with 2 h incubation time
with each substrate. After the reaction was terminated using the
supplied stop solution, the plate was read with the optical density
set at 405 nm using the TECAN Infinite M200Microplate Reader
(TECAN Group Ltd., Männedorf, SZ).
High Liquid Performance Chromatography
Analysis of Neurotransmitter Levels
Tissue samples of frontal cortex, striatum and brainstem
tissue were weighed before being homogenized in 0.5 M
perchloric acid. Following centrifugation and filtration through
0.1 µm filters (Ultrafree, Millipore, Temecula, CA, USA), the
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TABLE 1 | The experimental design of chronic mild stress in adult mice.
Week 1 Week 2 Week 3 Week 4
Mon Cage tilt (overnight) Bedding removal (overnight) Restraint stress (30 min) Wet bedding (overnight)
Tue Wet bedding (overnight) Isolation (overnight) Cage tilt (overnight) Water removal (6 h)
Wed Restraint stress (30 min) Food removal (6 h) Food removal (6 h) Cage tilt (overnight)
Thu Water removal (6 h) Cage tilt (overnight) Wet bedding (overnight) Cage swap and shaking
Fri Cage swap and shaking Cage swap and shaking Bedding removal (overnight) TST
Sat Light cycle reversed Light cycle reversed Light cycle reversed Light cycle reversed
Sun Light cycle reversed Light cycle reversed Light cycle reversed Light cycle reversed
supernatants were loaded into a HPLC autosampler and pump
(Dionex Ultimate 3000, ThermoFisher Scientific, Waltham,
MA, USA). For separation, a mobile phase consisting a 17.5%
methanol buffer (pH 3.0, 30 mM citrate-phosphate buffer, 2.1
mM octyl sodium sulfate, 0.1 mM EDTA, 10 mM NaCl), with
a flow rate of 0.5 ml/min was used. Detection was by the
Dionex Coulochem III Electrochemical detector (ThermoFisher
Scientific Inc., Waltham, MA, USA). Calculation of 5-HT and
5-HIAA levels were based on values derived from 5-HT and
5-HIAA standards (Sigma, St. Louis, MO, USA) using the
Chromeleon software (ThermoFisher Scientific Inc., Waltham,
MA, USA), and were normalized to wet tissue weight for analysis.
Serotonin turnover rate is taken as (amount of 5-HIAA)/(amount
of 5-HT).
Semi-Quantitative and Real-Time PCR
ProtoScript® M-MuLV First Strand cDNA Synthesis Kit (New
England Biolabs, MA, USA) was used to obtain cDNA from RNA
that was extracted from brain tissues and SH-SY5Y cells. Semi-
quantitative PCR (qPCR) was performed on the cDNA from
brain tissues using the following primers: monoamine oxidase
A (MAO A) Forward (5′- ACG GAT CTG GAG AAG CCC
AGT ATC - 3′), MAO A Reverse (5′ - TTC ACT TTA TCC
CCA AGG AGG ACC A - 3′), mTPH2 580F (5′ - GAT GTG
GCC ATG GGC TAT AAA - 3′), and mTPH2 869R (5′ - GTG
CAG TGG AAT ACT CTG TAG G - 3′). mRNA expression
was normalized to b-actin using the following primers: b-actin
forward (5′ - ACC CAC ACT GTG CCC ATC TA - 3′) and b-
actin Reverse (5′ - CGG AAC CGC TCA TTG CC - 3′). For SH-
SY5Y cells, the following primers were used: hMAO A Forward
(5′ - TGGAGAATCAAGAGAAGGCGAGTATCG - 3′), hMAO
A Reverse (5′ - TTCACTTGGTCTCCGAGGAGGTCCA - 3′),
and GAPDH Forward (5′ - TGCMTCCTGCACCACCAACT -
3′) and GAPDH Reverse (5′ - TGCCTGCTTCACCACCTTC
- 3′). Real-Time qPCR was performed on SH-SY5Y cells
with MAO A forward primer (5′ - TGGAGAATCAAGAGA
AGGCGAGTATCG - 3′) and MAO A reverse primer (5′
- ACCAACATCTACGTAATCAACATGCTCATTC - 3′), and
mRNA expression was normalized to GAPDH, using the forward
primer (5′ - ATGCCATCACTGCCACYCAGAAG - 3′) and the
reverse primer (5′ - TGCCAGTGAGCTTCCCGTTCAG - 3′).
Western Blots
Brain tissues and SH-SY5Y cell pellets were homogenized on
ice in a 4% sodium dodecyl sulphate (SDS). Fifty micrograms
of protein extracts were resolved on 7.5% SDS-polyacrylamide
gels and transferred onto nitrocellulose membranes (Bio-Rad,
CA, USA). Immunoblots of striatum and brainstem samples, and
SH-SY5Y cells were probed with MAO A antibody (Santa Cruz,
Dallas, TX, USA; 1:200) and Actin (Millipore, Temecula, CA,
USA; 1:100000). Protein extracts from the MAO A knockout
mice, which were kindly gifted by Dr. Jean Shih JC (USC, USA),
were run as negative controls for MAO A antibody staining.
Immunoblots of brainstem samples were further probed with
glucocorticoid antibody (ThermoScientific, IL, USA; 2.5µg/mL).
Image J software (NIH, USA) was used for densitometric analyses
and relative levels of proteins were normalized against actin as a
loading control.
Statistical Analysis
Data were analyzed using the R statistical program. Data are
expressed as mean ± SEM and p < 0.05 was considered as
statistically significant. One-way or two-way ANOVAs (factors:
genotype and treatment) were used to assess the behavioral,
corticosterone and neurochemical data for chronic stress and
MS. A two-tailed, Student’s t-test was used to assess all other
datasets. Bonferroni-corrected pairwise comparisons were used
as post hoc tests.
Results
Effects of Chronic Mild Stress Applied During
Adulthood
Exposure to 4 weeks of chronic unpredictable stress (CMS)
during adulthood did not affect the behaviors of adult WT and
TPH2 KI mice, as a two-way ANOVA for the percentage of time
spent immobile in the TST only showed a significant main effect
of genotype (F(1,24) = 18.4, p < 0.001; Figure 1A). Both CMS
and control TPH2 KI mice exhibited increased depressive-like
behaviors than their WT counterparts, and these two TPH2 KI
groups did not behave differently from each other.
At baseline, corticosterone levels in TPH2 KI mice were
significantly higher thanWT controls (F(1,27) = 7.432, p = 0.0111;
Figure 1B). The mean corticosterone concentration in the serum
of WT mice was 41908 (SE = 2546) pg/ml and of TPH2 KI
mice was 56505 (SE = 4590) pg/ml. In CMS groups, there
was a significant main effect of CMS on serum corticosterone
levels (F(1,46) = 9.21, p = 0.00396), with no significant main
effect of genotype or interaction. Serotonin levels in brainstem
tissue showed significant main effects of genotype (F(1,78) = 32.3,
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FIGURE 1 | Effects of chronic mild stress applied during adulthood.
(A) Chronic mild stress during adulthood had no effect on the time spent
immobile in the tail suspension test in both WT and TPH2 KI mice. (B) Chronic
mild stress decreased levels of serum corticosterone for both genotypes. (C)
Serotonin levels in the brainstems of control and CMS TPH2 KI mice were
lower than control WT mice. No differences in serotonin levels were detected
between control and CMS WT mice. N = 10–20 mice/genotype/treatment
condition.ap < 0.05 from WT control, cp < 0.05 from WT stress. Figure key:
White, open bar—WT non-stressed controls; white horizontal striped bar—WT
CMS; gray open bar—TPH2 KI, non-stressed controls; gray, horizontal striped
bar—TPH2 KI CMS.
p < 0.0001; Figure 1C), with no significant main effect of CMS
or interaction.
Effects of Maternal Separation on Adult
Behaviors
Newborn pups were subjected to MS stress for 3 h each day
starting from postnatal day 1 to day 14, after which, the pups were
left undisturbed until adulthood at 2 months old. At adulthood,
the MS pups and their controls (non-MS) were subjected to a
series of behavior tests.
In the zero maze (Figures 2A,B), there were significant
main effects of genotype (time: F(1,70) = 19.2, p < 0.0001;
transition: F(1,70) = 23.9, p< 0.0001) andMS (time: F(1,70) = 9.57,
p = 0.00279; transition: F(1,70) = 12.9, p = 0.0006), with significant
genotype by MS interaction (time: F(1,70) = 16.0, p = 0.000149;
transition: F(1,70) = 25.4, p < 0.0001). Non-MS TPH2 KI mice
showed decreased time spent in the open arms (Figure 2A)
and reduced number of transitions between the open arms
(Figure 2B) compared to non-MS WT mice. MS WT mice
also had significantly decreased exploratory measures in the
zero maze compared to non-MS WT mice (ps < 0.001) and
exhibited similar levels of anxiety-like behaviors to non-MS and
MS TPH2 KI mice, which in turn were not significantly different
from each other. In the light/dark box (Figures 2C,D), the
two-way ANOVA showed a significant main effects of genotype
(time: F(1,75) = 6.04, p = 0.00163; horizontal activity: F(1,75)
= 5.71, p = 0.0194) and MS (time: F(1,75) = 20.5, p < 0.0001;
horizontal activity: F(1,75) = 5.21, p = 0.0253). The genotype
by MS interaction term was significant for both percentage
time spent (F(1,75) = 4.11, p = 0.0444) and horizontal activity
(F(1,75) = 5.10, p = 0.0268). Pairwise comparisons showed that
MS WT, non-MS TPH2 KI and MS TPH2 KI had significantly
reduced percent time spent (Figure 2C) and horizontal activity
(Figure 2D) in the light box when compared to non-MS WT (ps
FIGURE 2 | Effects of maternal separation on adult behaviors. In panels
(A–E), non-MS and MS TPH2 KI exhibit increased anxiety-like and
depressive-like behaviors compared to non-MS WT in all behavioral tests. In
the zero maze, MS WT had reduced percentage of time spent in the open arm
(A) and number of transitions between the two closed arms (B) compared to
non-MS WT. In the light/dark box, MS WT had reduced percentage of time
spent in the light box (C) and horizontal activity in the light box (D) compared
to non-MS WT. (E) MS increased the percentage of time spent immobile in the
tail suspension test in WT, but not in TPH2 KI mice. N = 10–30
mice/genotype/treatment condition. ap < 0.05 from WT control. Figure key:
White, open bar—WT non-stressed controls; white, diagonal striped bar—WT
MS; gray open bar—TPH2 KI, non-stressed controls; gray, diagonal striped
bar—TPH2 KI MS.
< 0.01). MS WT mice had similar exploratory levels in the light
box as non-MS and MS TPH2 KI mice.
In the TST (Figure 2E), there were significant main effects of
genotype (F(1,104) = 39.3, p < 0.001) and MS treatment (F(1,104)
= 14.8, p < 0.001), with significant genotype by MS treatment
interaction (F(1,104) = 8.23, p = 0.005). Within the non-MS
group, TPH2 KI mice remained immobile longer than WT mice
(p < 0.0001). WT and TPH2 KI mice that had undergone MS
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FIGURE 3 | Effects of maternal separation on serum corticosterone and
the serotonergic system in adulthood. (A) Corticosterone levels of both MS
WT and TPH2 KI mice were higher than their respective non-MS controls.
(B) Expression of glucocorticoid receptors in adult WT mice was reduced after
undergoing maternal separation. (C) Serotonin levels in three brain areas of
adult mice, the frontal cortex, striatum and brainstem, were lowered in MS WT
than non-MS WT. Both non-MS and MS TPH2 KI had significantly lowered
serotonin levels in all three brain areas compared to control or MS WT mice.
(D) Representative results of the semi-PCR for TPH2 and MAO A in adult
non-MS and MS WT mice. TPH2 expression remained unchanged (E), whereas
MAO A expression was increased (F), in both the brainstem and striatum of MS
compared to non-MS WT adult mice. (G) Representative blot of MAO A protein
expression in the brainstem of WT adult mice. (H) Western blot analyses of
adult brainstem and striatum showed that MAO A protein expression was
increased in MS WT mice relative to non-MS controls. For serum corticosterone
levels, N = 10–20 mice/genotype/treatment condition. For panels (B) to (H), N
= 5 mice/genotype/treatment condition. ap < 0.05 from WT control, bp < 0.05
from KI control, cp < 0.05 from WT stress. Figure key: White, open bar—WT
non-stressed controls; white, diagonal striped bar—WT MS; gray open
bar—TPH2 KI, non-stressed controls; gray, diagonal striped bar—TPH2 KI MS.
showed increased depressive-like behaviors compared to non-
MSWT mice (ps< 0.0001), and did not significantly differ from
non-MS TPH2 KI mice.
Effects of Maternal Separation on Serum
Corticosterone and the Serotonergic System in
Adulthood
In the MS groups, corticosterone measurements showed
significant effects of MS treatment (F(1,58) = 18.1, p < 0.001),
with no significant main effect of genotype or interaction
(Figure 3A). Within genotype, MS WT mice had higher
levels of corticosterone than non-MS WT mice (p = 0.00761),
whereas there was no significant difference in corticosterone
levels between non-MS and MS TPH2 KI mice. Additionally,
MS WT and MS TPH2 KI mice had similar levels of
corticosterone. In MS WT mice, GR expression levels were
reduced at adulthood, compared to controls (Figure 3B;
p = 0.006).
Neurochemical analyses of tissue levels of serotonin in the
frontal cortex, striatum and brainstem (Figure 3C) of non-
MS and MS, WT and TPH2 KI mice showed that there was
a significant main effect of genotype (Frontal cortex: F(1,32) =
1150, p < 0.001; Striatum: F(1,36) = 223, p < 0.001; Brainstem:
F(1,29) = 220 p < 0.001). The other main effect of MS treatment
also significantly affected tissue levels of serotonin (Frontal
cortex: F(1,32) = 14.5, p < 0.001; Striatum: F(1,36) = 9.53,
p = 0.00388; Brainstem: F(1,29) = 13.9, p < 0.001), and there
was a significant genotype by treatment interaction in all three
brain regions (Frontal cortex: F(1,32) = 23.1, p< 0.0001; Striatum:
F(1,36) = 10.1, p = 0.00308; Brainstem: F(1,29) = 8.65, p = 0.00638).
Pair-wise comparisons showed that non-MS TPH2 KI mice
showed significantly lower levels of serotonin in the tissue
compared to WT mice in all three brain regions (ps < 0.001).
Within genotype, MS WT mice showed significant reduction in
serotonin levels in all three brain regions compared to non-MS
WT counterparts (ps< 0.001), whereas there were no significant
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FIGURE 4 | Effects of maternal separation on glucocorticoid receptor
expression and the serotonergic system in 4-week-old mice.
(A) Expression of glucocorticoid receptors in 4-week-old WT mice was
reduced in those that underwent maternal separation. (B) Serotonin level in the
striatum of 4-week-old MS WT mice was lower than that of non-MS WT mice,
and (C) serotonin turnover was increased. (D) Representative blot of MAO A
protein expression in the brainstem of 4-week-old WT mice, and quantification
of western blot analyses of 4-week-old brainstem, which showed that MAO A
protein expression was increased in MS WT mice compared to controls. N = 5
mice/genotype/treatment condition. ap < 0.05 from WT control. Figure key:
White, open bar—WT, non-MS controls; diagonal striped bar—WT, MS.
difference in serotonin levels between the non-MS andMS TPH2
KI mice. Even though serotonin levels of maternally separated
WT mice were reduced, the levels in the frontal cortex, striatum
and brainstem were still higher than both non-MS andMS TPH2
KI mice (ps< 0.001).
Maternally Separated WT Mice Had Increased
MAO A Activity During Adulthood
To determine the underlying cause of the decreased serotonin
levels observed in MS WT mice, the expression levels of the
rate-limiting enzyme in serotonin production, TPH2, and the
enzyme that breaks down serotonin, MAO A, were measured.
The semi-qPCR results showed that TPH2 mRNA expression
levels in the brainstem and striatum (Figures 3D,E) of MS WT
mice were not different from non-MSWTmice, whereas mRNA
expression ofMAOA is increased inMSWTmice (Figures 3D,F;
ps < 0.007). The results of the semi-qPCR were corroborated by
western blot analyses of MAO A expression in adult WT mice,
FIGURE 5 | Twenty four hours Dex treatment increased MAO A
expression in SH-SY5Y cells. Quantification of mRNA expression (A) and
protein expression (B) showed that MAO A increased after 24 h treatment
with Dex (black bars) compared to DMSO treatment (white bars).
Representative results from semi-PCR and western blots are shown in panels
(A) and (B) respectively. N = 3 replicates. ap < 0.05 from DMSO control.
Figure key: White bar—DMSO-treated; black bar—Dex-treated.
where an increase in MAO A expression in maternally separated
WTmice, relative to controls, was observed in both the brainstem
and striatum (Figures 3G,H; ps< 0.002).
Maternally Separated WT Mice Had Increased
MAO A Activity at 4 Weeks of Age
In order to determine the point at which the biochemical changes
occurred, a separate batch of MS WT mice and their controls
were sacrificed at a younger timepoint of 4 weeks, and their brain
tissues harvested for biochemical analyses. Relative to control
WTmice, glucocorticoid receptor levels were reduced in MSWT
at 4 weeks of age (Figure 4A; p < 0.05). In addition, serotonin
levels were found to be lowered in the striatum of 4-week-old
MS mice compared to controls (F(1,25) = 9.44, p = 0.00508;
Figure 4B), with increased serotonin turnover (F(1,10) = 13.5,
p = 0.00115; Figure 4C). The increased MAO A expression
was also found in the brainstem of 4-week-old MS WT mice
(Figure 4D; p = 0.0054). Thus, the reduction of serotonin levels in
the brain followingMS is likely to be due to the higher expression
of MAO A, which resulted in increased serotonin turnover. In
addition, this perturbed expression level of MAO A is present in
4-week-old MSWT mice and persists into adulthood.
Dexamethasone Treatment Increased MAO A
Expression in SH-SY5Y Cells
We then used an in vitro system to investigate whether a
pharmacological stressor, Dex, will result in similar biochemical
responses that was observed in maternally separated WT mice.
Using neuronal SH-SY5Y cells, we showed that 24 h Dex
treatment resulted in significant increases in both mRNA and
protein expression levels of MAO A compared to the DMSO-
treated controls (Figure 5; ps< 0.01).
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FIGURE 6 | Dex treatment administered during adulthood did not affect
the serotonergic system. (A) 1 mg/kg Dex treatment for 5 days resulted in a
suppression of corticosterone in adults. (B) Glucocorticoid receptor
expression was reduced in Dex-treated adult mice. (C,D) There was no
detectable difference in serotonin level and turnover rate in the striatum of
adult, Dex-treated WT mice compared to controls. (E) Representative results
and quantification from semi-PCR analyses showing TPH2 and MAO A
expression in adult mice. No change was detected in TPH2 and MAO A gene
expression in the brainstem of adult, Dex-treated WT mice compared to
controls. (F) A representative western blot showing MAO A expression in the
brainstem from adult WT mice, and quantification of the western blot results
showing no change in MAO A protein expression in the brainstem and
striatum of adult, Dex-treated WT mice compared to controls. N = 12–15
mice/treatment condition for corticosterone and HPLC analyses; N = 5
mice/treatment condition for western blots and semi-PCR. ap < 0.05 from
Veh control. Figure key: White bar—Veh treated; black bar—Dex treated.
Dexamethasone Treatment During Adulthood did
not Affect the Serotonergic System Serotonin
Following the increased MAO A expression observed in SH-
SY5Y cells, we treated adult WT mice for 5 days with
1 mg/kg Dex. Corticosterone levels (p < 0.0001; Figure 6A)
and glucocorticoid receptor expression (p < 0.05; Figure 6B)
FIGURE 7 | Dex treatment administered during postnatal days 7–11
caused dysregulations in the serotonergic system at 4 weeks of age.
(A) Expression of glucocorticoid receptors in 4-week-old mice was reduced in
those that were treated with Dex during PND7–11. (B,C) At 4 weeks of age,
serotonin level was reduced and turnover rate was increased in mice that were
treated with Dex during PND7–11 compared to controls. (D) Representative
western blot showing MAO A expression in the brainstem of 4-week-old mice,
and quantification of western blot results from the brainstem and striatum of
4-week-old mice, which showed an increased in MAO A protein expression in
mice that were treated with Dex during PND7–11. N = 5 mice/treatment
condition. ap < 0.05 from Veh control. Figure key: White bar—Veh
treated/Non-MS; black bar—Dex treated.
were significantly reduced in Dex-treated WT mice compared to
vehicle-treated controls.
Neurochemical analyses showed no detectable change in
serotonin levels and turnover rate in the striatum of Dex-
treated WT mice relative to controls (Figures 6C,D). No
change was detected in the mRNA expression of TPH2 and
MAO A (Figure 6E). Additionally, the protein expression level
of MAO A remained unchanged in the brainstem and striatum
(Figure 6F). Hence, Dex treatment, when applied in adult mice
as a pharmacological manipulation to activate glucocorticoid
receptors, did not result in a dysregulation in serotonin levels and
MAO A expression levels when administered during adulthood.
Dexamethasone Treatment During Postnatal
Days 7–11 Caused Dysregulations in the
Serotonergic System at 4 Weeks of Age
Previous studies have shown that postnatal Dex treatment, which
began at PND7, resulted in a decrease of serotonin levels (Slotkin
et al., 2006). Here, we investigated if Dex treatment during this
postnatal period would affect MAO A expression, and hence
serotonin levels and turnover rate. Mice are sacrificed at 4 weeks
of age to show that biochemical changes were already present
even before adulthood. Dex treatment during postnatal days
7–11 significantly reduced glucocorticoid receptor expression
in 4-week-old WT mice (p < 0.05; Figure 7A). Neurochemical
analyses showed that serotonin levels in the striatum of PND7–11
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Dex-treated mice were lower (Figure 7B; p = 0.000523), whereas
serotonin turnover was higher, than that of controls (Figure 7C;
p = 0.00115). In addition, PND7–11 Dex-treated WT mice had
significantly higher MAO A protein expression levels in the
brainstem and striatum compared to DMSO-treated WT mice
(Figure 7D; p< 0.005).
Discussion
The key findings of this study are firstly that environmental
stressors, when applied during the early postnatal period,
will induce anxiety- and depressive-like behaviors through
dysregulations of the serotonergic system in WT mice, with
no detectable effects in TPH2 KI mice. Secondly, both
environmental and pharmacological stressors, when applied
during the early postnatal period, results in dysregulations of the
serotonergic system of WT mice. The reduced serotonin level in
the brains of WT mice that have been treated during early life
with either environmental or pharmacological stressors can be
attributed to an increase in MAO A expression.
Chronic Mild Stress and Maternal Separation
Had Different Effects on the Behavior and
Serotonergic System of WT Mice
Chronic mild stress has often been used as a model of depression
as it is able to induce anhedonia, as characterized by the
lack of sucrose preference, which is a hallmark symptom of
depression (Willner, 1997, 2005; Pothion et al., 2004). Here,
we found that chronic mild stress in adult WT mice resulted
in a suppression of corticosterone levels, which may be due
to adaptation following repeated stress episodes, as has been
shown previously (Chen and Herbert, 1995; Chung et al., 1999).
However, we did not observe any increase in behavioral despair,
as assessed by the TST. In addition, there were no detectable
differences in levels of serotonin in the brains of controls vs.
stressed groups. Our findings suggest that chronic mild stress
may not be a suitable stressor to reliably elicit a depressive-
like behavioral response in the WT mice, or that the C57/BL6J
genetic background of our mice has masked the effects of the
chronic mild stress manipulation (Willner, 2005; Mineur et al.,
2006).
In maternally separated WT mice, we showed that the
manipulation resulted in the exhibition of anxiety- and
depressive-like behaviors. The MS paradigm is often used to
mimic neglect (Meaney et al., 1985; Plotsky and Meaney, 1993;
Newport et al., 2002), and there is a wealth of studies showing
that MS in WT mice and rats chronically impairs emotional and
neuroendocrine responses. Our results are corroborated bymany
previous studies, which showed that MS of mouse or rat pups
caused long-term changes in behaviors associated with anxiety
and depression, even if compensatory postnatal maternal care
was present (Plotsky and Meaney, 1993; Wigger and Neumann,
1999; MacQueen et al., 2003; Romeo et al., 2003; Veenema
et al., 2006; Wei et al., 2010; Niwa et al., 2011; Sachs et al.,
2013).
Additionally, the disrupted maternal care in WT mice
may cause dysregulations in the corticosterone levels,
which may in turn affect the growth and development of
the central nervous system, and subsequently behavior in
adulthood (Plotsky and Meaney, 1993; Ladd et al., 1996;
Huot et al., 2002; Nishi et al., 2013). Here, we observed
an increase in serum corticosterone levels of adult WT
mice that underwent MS, which is in congruence with past
studies showing that early life stress, such as repeated MS
and isolation rearing, results in elevated levels of circulating
corticosterone (Lippmann et al., 2007; Niwa et al., 2011). We
also showed the glucocorticoid receptor expression was reduced
in maternally separated WT mice compared to controls, which
is likely due to the presence of elevated corticosterone levels
(Sapolsky et al., 1984; Meaney et al., 1985; Rosewicz et al.,
1988).
Previous studies have shown that the type of stressors applied
can affect serotonin levels in brain tissue (Kirby et al., 1995,
1997). Here, we found that MS resulted in lowered serotonin
levels in three brain areas, the brainstem, striatum and frontal
cortex in adult WT mice. Furthermore, analysis of brain samples
from an earlier timepoint of 4 weeks showed that serotonin levels
were already reduced, and serotonin turnover rate was increased.
Hence, we showed that serotonin dysregulation was present in
MSWT mice at periadolescence, and persisted into adulthood.
The effects of MS on serotonin levels and turnover suggested
that serotonin synthesis or breakdown was dysregulated. As
such, we characterized the expression levels of TPH2 and MAO
A in 4 week old and adult WT, maternally separated and
control mice. We observed an upregulation of the mRNA and
protein expression levels of MAO A, in both age groups of
maternally separated WT mice. Similarly, an earlier study using
chronic socially defeated rats showed that chronic social defeat
stress caused an elevation in corticosterone levels, decrease in
serotonin levels and increased MAO A activity in the cortex
and thalamus (Grunewald et al., 2012). Interestingly, TPH2
levels in maternally separated WT mice were no different from
that of controls, even though previous studies have shown
that both acute and chronic environmental (sound) stressors
or pharmacological (corticosterone hemisuccinate) stressors can
affect TPH2 activity (Azmitia and McEwen, 1976; Boadle-Biber
et al., 1989). However, the results from a study on rats that
were exposed to stress in early life were in line with what
we have found here, essentially that corticosterone level was
increased, serotonin level was reduced and serotonin turnover
was increased, with no changes in the expression levels of TPH2
(Mesquita et al., 2007). Hence, we suggest that the type of stressor
used and the timepoint of application of the stressor play a role
in determining whether TPH2 activity is affected. Here, we find
that MS only affects MAO A, and not TPH2 activity. Therefore,
we hypothesized that the elevation of corticosterone levels in
maternally separated mice may be the cause of the observed
upregulation of MAO A, which in turn increases serotonin
turnover.
Our results show that MS results in the exhibition of
adverse behaviors, and dysregulates corticosterone levels and
the serotonergic system of adult WT mice, whereas chronic
mild stress did not. Taken together, the presence of a critical
window during the developmental period may be another
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plausible explanation for the lack of perturbed behavioral and
neurochemical regulation in WT mice that underwent chronic
mild stress. Perhaps when chronic environmental stressors
are applied during early life (first 14 days), they will cause
long-lasting alterations in serum corticosterone level and the
serotonergic system, which in turn result in the manifestations of
aberrant behaviors and decreased serotonin levels in the brain.
This idea of a critical period for stressors to have permanent
effects on the serotonergic system has been shown previously
(Slotkin et al., 2006).
Chronic Mild Stress and Maternal Separation did
not Affect the Behaviors and Serotonergic
System of TPH2 KI Mice
For TPH2 KI mice, we found that they had slightly higher levels
of basal corticosterone than their WT counterparts. Although
this was not previously observed (Sachs et al., 2013), our results
are in congruence with previous studies using pharmacological
manipulations, which have shown that prolonged serotonin
depletion in rodents resulted in elevated corticosterone levels
(Baumann et al., 1998; Chung et al., 1999; Franklin et al., 2011).
We found that corticosterone levels were suppressed in TPH2
KI mice that were exposed to chronic mild stress and elevated
in maternally separated TPH2 KI mice relative to non-stressed
TPH2 KI mice. Thus, the corticosterone response of TPH2 KI
mice to stress follows a pattern similar to that of WT mice that
underwent either chronic mild stress or MS.
The unexpected findings of our study were that MS did not
give rise to behavioral changes or serotonergic perturbations
in TPH2 KI mice. The lack of observable behavioral changes
in TPH2 KI mice after MS has also been observed in a
previous study (Sachs et al., 2013). We suggest that this may
be because the TPH2 KI mice, due to their reduced serotonin
levels, already show anxiety- and depressive-like behaviors,
and reduced serotonin levels at baseline (Zhang et al., 2005;
Beaulieu et al., 2008; Jacobsen et al., 2012b), such that it is
physiologically not possible to show exacerbated anxiety- or
depressive-like phenotype in response to MS. However, MS
has been shown to affect other aspects of behavior in TPH2
KI mice, such as impaired behavioral inhibition (Sachs et al.,
2013).
Effects of Dexamethasone as a Pharmacological
Stressor on the Serotonergic System
In order to test whether the increased MAO A expression in
maternally separated WTmice is directly due to the activation of
glucocorticoid receptors as a result of the elevated corticosterone
levels, we used Dex, a synthetic glucocorticoid, to induce a
stress response in an in vitro system as a start. Using SH-SY5Y
neuronal cell line, our results, which were in line with that of
previous studies, showed an upregulation of MAO A mRNA
and protein expression following Dex treatment, likely through
the glucocorticoid-mediated activation of the MAO A promoter
(Manoli et al., 2005; Ou et al., 2006; Grunewald et al., 2012).
In order to test our hypothesis that there is a critical
developmental period during which chronic environmental
stressors caused the observed perturbations in the serotonergic
system, we treated PND7 or adult WT mice with 5 days of
Dex. These timepoints were chosen to mirror the timepoints
for MS and chronic mild stress. In both groups of Dex-treated
mice, we observed similar reductions in glucocorticoid receptor
expression. Interestingly, WT mice that were treated with Dex
during PND7–11, but not those treated during adulthood,
showed an increased in MAO A gene and protein expression,
with the corresponding reduced serotonin levels and increased
serotonin turnover. This further supports the idea that stressors
when applied during a critical developmental period, will
result in long-lasting, adverse effects on serotonergic regulation,
thereby leading to undesirable behavioral outcomes.
Concluding Remarks
Taken together, our results showed that stressors, be it
environmental or pharmacological, would have adverse effects
when applied during the critical postnatal period of at least from
day 1–14, or perhaps the narrower day 7–11, but not during
adulthood. To our knowledge, this is the first study showing
that the interplays between early life stress and serotonergic
homeostasis occur through the glucocorticoid regulation of
MAO A, and not TPH2, expression. This leads to long-lasting
perturbations in the serotonergic system, and results in anxiety-
and depressive-like behaviors.
Our results have clinical implications, because an elevation
of MAO A has been found in patients with major depressive
disorder (Meyer et al., 2009; Chiuccariello et al., 2014) and is
a contributing factor to postpartum depression (Sacher et al.,
2010). This suggests that maternally separated or postnatal Dex-
treatedWTmice can be used as a valid disease model to study the
underlying biological dysregulations of this group of depressive
disorders. It also stands to reason that the adverse effects of early
life chronic stress that we have observed can be rescued by the
direct manipulation of MAO A activity. Indeed, there has been
an increasing focus on the use of second generation, reversible
MAO A inhibitors for the treatment of drug-resistant depression
patients (Lum and Stahl, 2012; Schwartz, 2013; Shulman et al.,
2013). As such, it would be interesting for future studies to
investigate whether the long-lasting of effects of MS can be
antagonized by the application of MAO A inhibitors, or whether
lacking a functional MAO A gene can confer resistance to
stressors (Popova et al., 2006). In addition, it would be interesting
to follow-up on whether treating WT mice with a glucocorticoid
receptor antagonist during the MS manipulation will prevent the
development of the anxiety-like and depressive-like behaviors,
and perturbations of the serotonergic system. Additionally, it
has been found that MS affects NMDA receptor 1 expression
(Sachs et al., 2013), and that there is evidence of interplay
betweenMAOA and NMDA receptors (Kosenko and Kaminsky,
2009; Bortolato et al., 2012). Given these evidence, using this
mouse model of early life environmental or pharmacological
stress may also be useful in elucidating and understanding
the effects of NMDA receptor antagonists, such as ketamine,
which have recently demonstrated promise in the treatment
of drug-resistant depression (Zarate et al., 2006; Autry et al.,
2011).
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